Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

During the Trading Day
9.53 +0.41 / +4.50%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.53 +0.0019 / +0.02%
 
Volume: 1.6K

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 25.00, with a high estimate of 25.00 and a low estimate of 25.00. The median estimate represents a +162.33% increase from the last price of 9.53.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in InVivo Therapeutics Holdings Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19
Sales
$0.00
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.52%
 
 
 
 
 
 
Growthannually 21.25%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.